Home
About
Overview
Sharing Data
ORCID
Help
History (4)
BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience.
Clinical and Molecular Features of KRAS-Mutated Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.
Diagnosis and management of typical and atypical lung carcinoids.
Increasing clinician participation in tobacco cessation by an implementation science-based tobacco cessation champion program.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Diagnosis and management of typical and atypical lung carcinoids.
Diagnosis and management of typical and atypical lung carcinoids. Crit Rev Oncol Hematol. 2016 Apr; 100:167-76.
View in:
PubMed
subject areas
Biomarkers, Tumor
Carcinoid Tumor
Carcinoma, Large Cell
Cytodiagnosis
Diagnostic Imaging
Humans
Lung Neoplasms
Neoplasm Metastasis
Neuroendocrine Tumors
Small Cell Lung Carcinoma
authors with profiles
Marina Chiara Garassino